Advisor Group Holdings, Inc. Oramed Pharmaceuticals Inc. Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,549 shares of ORMP stock, worth $10,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,549

Previous 3,849 18.19%

Holding current value

$10,280

Previous $9,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$2.0 - $2.62 $1,400 - $1,834	700 Added 18.19%	4,549 $9,000
Q2 2024 Aug 13, 2024	SELL	$2.07 - $2.83 $1,655 - $2,264	-800 Reduced 17.21%	3,849 $9,000
Q1 2024 May 10, 2024	SELL	$2.18 - $3.58 $8,131 - $13,353	-3,730 Reduced 44.52%	4,649 $13,000
Q4 2023 Feb 12, 2024	SELL	$1.71 - $2.57 $19,323 - $29,041	-11,300 Reduced 57.42%	8,379 $19,000
Q3 2023 Nov 13, 2023	BUY	$2.51 - $3.55 $8,634 - $12,212	3,440 Added 21.18%	19,679 $51,000
Q2 2023 Aug 10, 2023	SELL	$2.12 - $4.47 $3,852 - $8,121	-1,817 Reduced 10.06%	16,239 $58,000
Q1 2023 May 12, 2023	SELL	$1.93 - $13.1 $8,497 - $57,679	-4,403 Reduced 19.6%	18,056 $39,000
Q4 2022 Feb 10, 2023	SELL	$5.88 - $12.03 $13,182 - $26,971	-2,242 Reduced 9.08%	22,459 $270,000
Q3 2022 Nov 14, 2022	BUY	$4.6 - $9.91 $25,290 - $54,485	5,498 Added 28.63%	24,701 $161,000
Q2 2022 Aug 10, 2022	BUY	$3.72 - $9.0 $10,598 - $25,641	2,849 Added 17.42%	19,203 $88,000
Q1 2022 May 04, 2022	SELL	$8.19 - $13.89 $9,959 - $16,890	-1,216 Reduced 6.92%	16,354 $137,000
Q3 2021 Nov 05, 2021	BUY	$12.13 - $23.82 $121,081 - $237,771	9,982 Added 131.55%	17,570 $386,000
Q2 2021 Aug 02, 2021	BUY	$8.34 - $14.59 $23,877 - $41,771	2,863 Added 60.59%	7,588 $101,000
Q1 2021 May 13, 2021	BUY	$4.22 - $11.33 $15,719 - $42,204	3,725 Added 372.5%	4,725 $48,000
Q4 2020 Feb 10, 2021	BUY	$2.48 - $4.64 $2,480 - $4,640	1,000 New	1,000 $4,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $4.12 $2,870 - $4,120	-1,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$2.6 - $5.5 $2,600 - $5,500	1,000 New	1,000 $3,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

8.21M

Call Options Held

11.2K

Put Options Held

200

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $87.7M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Oramed Pharmaceuticals Inc. Transaction History